Global Digital Therapeutics Market Overview:
Global Digital Therapeutics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Digital Therapeutics Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Digital Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Digital Therapeutics Market:
The Digital Therapeutics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Digital Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Digital Therapeutics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Digital Therapeutics market has been segmented into:
software and services and devices
By Application, Digital Therapeutics market has been segmented into:
preventive (pre-diabetes
obesity
smoking cessation
and others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Digital Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Digital Therapeutics market.
Top Key Players Covered in Digital Therapeutics market are:
Koninklijke Philips N.V.
(BioTelemetry
Inc.)
CANARY HEALTH
Livongo Health
Pear Therapeutics
Omada Health
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Digital Therapeutics Market Type
4.1 Digital Therapeutics Market Snapshot and Growth Engine
4.2 Digital Therapeutics Market Overview
4.3 software and services and devices
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 software and services and devices: Geographic Segmentation Analysis
Chapter 5: Digital Therapeutics Market Application
5.1 Digital Therapeutics Market Snapshot and Growth Engine
5.2 Digital Therapeutics Market Overview
5.3 preventive (pre-diabetes
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 preventive (pre-diabetes: Geographic Segmentation Analysis
5.4 obesity
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 obesity: Geographic Segmentation Analysis
5.5 smoking cessation
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 smoking cessation: Geographic Segmentation Analysis
5.6 and others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 and others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Digital Therapeutics Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 KONINKLIJKE PHILIPS N.V.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 (BIOTELEMETRY
6.4 INC.)
6.5 CANARY HEALTH
6.6 LIVONGO HEALTH
6.7 PEAR THERAPEUTICS
6.8 OMADA HEALTH
6.9 INC.
Chapter 7: Global Digital Therapeutics Market By Region
7.1 Overview
7.2. North America Digital Therapeutics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 software and services and devices
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 preventive (pre-diabetes
7.2.3.2 obesity
7.2.3.3 smoking cessation
7.2.3.4 and others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Digital Therapeutics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 software and services and devices
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 preventive (pre-diabetes
7.3.3.2 obesity
7.3.3.3 smoking cessation
7.3.3.4 and others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Digital Therapeutics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 software and services and devices
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 preventive (pre-diabetes
7.4.3.2 obesity
7.4.3.3 smoking cessation
7.4.3.4 and others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Digital Therapeutics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 software and services and devices
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 preventive (pre-diabetes
7.5.3.2 obesity
7.5.3.3 smoking cessation
7.5.3.4 and others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Digital Therapeutics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 software and services and devices
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 preventive (pre-diabetes
7.6.3.2 obesity
7.6.3.3 smoking cessation
7.6.3.4 and others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Digital Therapeutics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 software and services and devices
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 preventive (pre-diabetes
7.7.3.2 obesity
7.7.3.3 smoking cessation
7.7.3.4 and others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Digital Therapeutics Scope:
|
Report Data
|
Digital Therapeutics Market
|
|
Digital Therapeutics Market Size in 2025
|
USD XX million
|
|
Digital Therapeutics CAGR 2025 - 2032
|
XX%
|
|
Digital Therapeutics Base Year
|
2024
|
|
Digital Therapeutics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Koninklijke Philips N.V.,(BioTelemetry, Inc.), CANARY HEALTH, Livongo Health, Pear Therapeutics, Omada Health, Inc..
|
|
Key Segments
|
By Type
software and services and devices
By Applications
preventive (pre-diabetes
obesity
smoking cessation
and others
|
